I just looked on the NICE website, they did a review of canaloplasty in 2022 and found no significant issues with safety and efficacy and recommend the procedure (amongst other MIGS). They did indicate they'd prefer more data, so it would be nice to see a new review that incorporates the large volume of addition data supporting efficacy since that review was done
- Forums
- ASX - By Stock
- EYE
- POTENTIAL RE-RATE CATALYST EVENT: RESULTS
POTENTIAL RE-RATE CATALYST EVENT: RESULTS, page-107
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
23.0¢ |
Change
0.005(2.22%) |
Mkt cap ! $52.68M |
Open | High | Low | Value | Volume |
23.0¢ | 24.0¢ | 23.0¢ | $36.78K | 159.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 52300 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 53718 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 52300 | 0.225 |
7 | 275860 | 0.220 |
1 | 20000 | 0.215 |
6 | 231583 | 0.210 |
6 | 104536 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 3617 | 1 |
0.240 | 7967 | 2 |
0.245 | 88888 | 1 |
0.250 | 227593 | 5 |
0.255 | 100000 | 1 |
Last trade - 14.44pm 23/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online